Serum amyloid A (SAA) denotes a family of small apolipoproteins that circulate in the bloodstream and rise dramatically during acute and chronic inflammatory states. SAAs are classed as acute‑phase proteins because their plasma concentration can increase manyfold in response to infection, injury, or systemic inflammation. They are found across vertebrate species and are conserved in structure and function.

Structure and isoforms

Multiple SAA genes produce closely related proteins. In humans the best characterized are SAA1 and SAA2, which are inducible during the acute‑phase response, and SAA4, which is expressed at lower, constitutive levels. Other species may express additional isoforms; for example, SAA3 is functional in some animals but is a pseudogene in humans. Molecularly, SAAs are small, amphipathic proteins that associate with high‑density lipoproteins (HDL).

Production and regulation

The liver is the principal site of SAA synthesis, where hepatocytes increase SAA gene transcription under the influence of proinflammatory cytokines such as interleukin‑1, interleukin‑6 and tumor necrosis factor. For a basic reference to their circulation see blood, and for their hepatic origin see liver. Levels rise rapidly after inflammatory stimuli and fall as the stimulus resolves.

Biological roles

SAAs have several functions that connect lipid metabolism and innate immunity. Key activities include:

  • Redistribution of cholesterol: SAAs can transfer cholesterol to the liver for excretion and remodel HDL particles.
  • Immune modulation: they can act as chemoattractants, influence cytokine production, and affect leukocyte behavior.
  • Tissue repair: SAAs are implicated in processes that follow injury and infection, although details remain under study.

Clinical significance and disease associations

Clinically, SAA is a sensitive biomarker of inflammation and is measured in research and some clinical settings as an alternative or complement to C‑reactive protein. Persistently high SAA concentrations are implicated in AA (secondary) amyloidosis, a condition in which fragments of SAA aggregate as insoluble fibrils and deposit in organs, potentially causing dysfunction. Elevated SAA has also been associated with chronic inflammatory diseases such as rheumatoid arthritis and has been studied for links with cardiovascular risk, though causal relationships are complex; see discussions of inflammation and cardiovascular disease.

Measurement and research directions

SAA is measured by immunoassays and can guide assessment of disease activity in certain inflammatory conditions. Ongoing research explores its precise roles in HDL biology, its signaling actions on immune cells, and how SAA contributes to amyloid formation. Understanding these pathways could inform therapies aimed at preventing amyloid deposition or modulating inflammatory damage.